Archive: 15/04/2018

First-in-human clinical trial of new targeted therapy drug reports promising responses for multiple

A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Center reveals for the first time, an investigational drug that is effective and safe for patients with cancers caused by an alteration in ...

Apr 15, 2018

New liquid biopsy-based cancer model reveals data on deadly lung cancer

Small cell lung cancer (SCLC) accounts for 14 percent of all lung cancers and is often rapidly resistant to chemotherapy resulting in poor clinical outcomes. Treatment has changed little for decades, but a study at The University ...

Apr 15, 2018

Archive: 15/04/2018

First-in-human clinical trial of new targeted therapy drug reports promising responses for multiple

New liquid biopsy-based cancer model reveals data on deadly lung cancer

Phys.org

Tech Xplore

Science X